Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway
Leyi Ma,Fan Wu,Qingqing Shao,Guang Chen,Lijun Xu,Fuer Lu
DOI: https://doi.org/10.2147/DDDT.S319260
2021-07-21
Abstract:Leyi Ma, 1, &ast Fan Wu, 1, &ast Qingqing Shao, 1 Guang Chen, 2 Lijun Xu, 1 Fuer Lu 1 1 Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2 Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fuer Lu Email Background: Oxidative stress and inflammation play essential roles in the development and progression of diabetic nephropathy (DN). Baicalin (BAI), a natural flavonoid, has been showed to have a renoprotective effect in various renal diseases. However, its underlying mechanisms in DN remain unclear. In this study, we explored the potential effects and underlying mechanisms of BAI on DN using a spontaneous DN model. Methods: The protective effects of BAI on DN have been evaluated by detecting DN-related biochemical indicators, kidney histopathology and cell apoptosis. After that, we examined the level of renal oxidative stress and inflammation to explain BAI's renoprotective effects. Then, Nrf2 pathway was tested to clarify its antioxidant activity, and kidney transcriptomics was conducted to elucidate its anti-inflammatory activity. Finally, Western blot was applied for final mechanism verification. Results: Our results found that BAI effectively ameliorated diabetic conditions, proteinuria, renal histopathological changes and cell apoptosis in DN. BAI significantly improved the kidney levels of glutathione peroxidase (GSH-PX), superoxide dismutase (SOD) and catalase (CAT), and reduced malondialdehyde (MDA) level. Meanwhile, the infiltration of inflammatory cells including T-lymphocytes, T-helper cells, neutrophils and macrophages, and the mRNA levels of pro-inflammatory cytokines (IL-1β, IL-6, MCP-1 and TNFα) were also obviously inhibited by BAI. Afterward, Western blot found that BAI significantly activated Nrf2 signaling and increased the expression of downstream antioxidant enzymes (HO-1, NQO-1). Kidney transcriptomics revealed that the inhibition of MAPK signaling pathway may contribute to BAI's anti-inflammatory activity, which has also been verified in later experiment. BAI treatment did obviously inhibit the activation of canonical pro-inflammatory signaling pathway MAPK family, such as Erk1/2, JNK and P38. Conclusion: In summary, our data demonstrated that BAI can treat DN by alleviating oxidative stress and inflammation, and its underlying mechanisms were associated with the activation of Nrf2-mediated antioxidant signaling pathway and the inhibition of MAPK-mediated inflammatory signaling pathway. Keywords: baicalin, diabetic nephropathy, oxidative stress, inflammation, Nrf2, MAPK Diabetic nephropathy (DN) is one of the major diabetic microvascular complications, which has surpassed glomerulonephritis as the primary cause of chronic kidney disease (CKD) in China. 1 , 2 It was reported that more than 15–40% patients with diabetes mellitus (DM) may develop DN during their lifespan, 3 and part of them eventually progresses to end-stage renal disease (ESRD). Currently, there is no satisfactory approach for the prevention and treatment of DN. Although tight glycemic control and blood pressure control have been proven to be effective, but many patients on oral hypoglycemic agents combined with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockades (ARBs) continue to progress to ESRD, and patients' survival rate also has no significant improvement due to the limited efficacy and some side effects. 2 , 4 Therefore, the development of novel agents is of great value in the treatment of DN. The typical pathological characteristics of DN including tubular epithelial cell damage, glomerular sclerosis, apoptosis, inflammatory infiltration and renal interstitial fibrosis. 5 To date, the pathogenesis of DN remains unclear. A number of evidences have suggested that oxidative stress and inflammation play the key roles in the development of DN. 6–8 Mechanically, chronic hyperglycemia in DM patients is regarded as a trigger to initiate the downstream cascade. 9 Briefly, hyperglycemia can induce the excessive production of reactive oxygen species (ROS), which invariably leads -Abstract Truncated-